Adastra Holdings Ltd. (CSE: XTRX)

Market Cap	1.76M
Revenue (ttm)	25.11M
Net Income (ttm)	-2.64M
Shares Out	5.60M
EPS (ttm)	-0.47
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Open	0.305
Previous Close	0.400
Day's Range	0.305 - 0.305
52-Week Range	0.120 - 2.900
Beta	-0.36
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 29, 2024

About Adastra Holdings

Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada. The company offers vape pens, wax, resin, infused pre-rolls, diamonds, and shatters under the Endgame brand name. It also provides consulting, white label manufacturing, and tolling services; and licenses its intellectual property for the sale of consumer-packaged goods. The company was formerly knowns as Phyto Extractions Inc. and changed its name to Adastra Holdings Ltd. in September 2021. Adastra Holdings Ltd. is based in Langley, Canada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Lachlan McLeod
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: XTRX

Financial Performance

In 2023, Adastra Holdings's revenue was 22.22 million, an increase of 67.15% compared to the previous year's 13.30 million. Losses were -3.54 million, -17.21% less than in 2022.